December 2014 | Oncology Live Urologists in Cancer Care®

December 31, 2014

A biomarker has been found that may help determine which Gleason 7 (GS7) cancers are particularly aggressive.

December 28, 2014

It's not uncommon for a business to use a superlative in its name, but Premier Medical Group in Poughkeepsie, NY, truly lives up to its moniker.

December 27, 2014

One-third of men over 70 years of age who undergo radical prostatectomy for prostate cancer and then experience biochemical recurrence have no need for salvage treatment, according to a recent study.

December 24, 2014

Urologists who are members of LUGPA are doing the right thing by being part of large group practices.

December 22, 2014

Drugs that inhibit the DNA repair enzyme poly(ADP-ribose) polymerase (PARP) have been shown to be effective in treating ovarian, breast, and prostate cancers in patients with inherited BRCA mutations. In broadening the therapeutic scope of PARP inhibitors beyond germline BRCA-mutated cancers.

December 20, 2014

Fats in blood and on the body increase men's prostate cancer risk, two studies have found.

December 20, 2014

The use of multiparametric MRI in diagnosing and treating prostate cancer was explored in November during a continuing medical education course offered at the annual meeting of LUGPA

December 17, 2014

While Laszewski said the Affordable Care Act (ACA), which is driving many of the changes, may end up being altered, he doesn't expect the program to be disbanded due to the political shift in legislative power.

December 15, 2014

In a constantly changing and thus difficult-to-navigate healthcare world, thriving in community practice is nothing if not challenging.

December 15, 2014

In attending the Society of Urologic Oncology's annual meeting in Bethesda in early December, I was struck by the number of presentations focusing sharply on the burgeoning fields of biomolecular markers and immunotherapy and their application to urologic oncology.